SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-043355
Filing Date
2021-03-29
Accepted
2021-03-29 17:08:44
Documents
82
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm219286d1_10k.htm 10-K 1007597
2 EXHIBIT 3.2 tm219286d1_ex3-2.htm EX-3.2 245545
3 EXHIBIT 4.9 tm219286d1_ex4-9.htm EX-4.9 8162
4 EXHIBIT 31.1 tm219286d1_ex31-1.htm EX-31.1 9093
5 EXHIBIT 31.2 tm219286d1_ex31-2.htm EX-31.2 9162
6 EXHIBIT 32.1 tm219286d1_ex32-1.htm EX-32.1 4516
7 EXHIBIT 32.2 tm219286d1_ex32-2.htm EX-32.2 4540
  Complete submission text file 0001104659-21-043355.txt   5837063

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT scps-20201231.xml EX-101.INS 1035236
9 XBRL TAXONOMY EXTENSION SCHEMA scps-20201231.xsd EX-101.SCH 67761
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scps-20201231_cal.xml EX-101.CAL 46991
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scps-20201231_def.xml EX-101.DEF 215067
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE scps-20201231_lab.xml EX-101.LAB 494997
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scps-20201231_pre.xml EX-101.PRE 418901
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39788 | Film No.: 21782494
SIC: 2834 Pharmaceutical Preparations